1. Home
  2. GETY vs KROS Comparison

GETY vs KROS Comparison

Compare GETY & KROS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Getty Images Holdings Inc.

GETY

Getty Images Holdings Inc.

HOLD

Current Price

$1.33

Market Cap

540.6M

Sector

Industrials

ML Signal

HOLD

Logo Keros Therapeutics Inc.

KROS

Keros Therapeutics Inc.

HOLD

Current Price

$17.86

Market Cap

584.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GETY
KROS
Founded
1995
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
540.6M
584.9M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
GETY
KROS
Price
$1.33
$17.86
Analyst Decision
Buy
Buy
Analyst Count
4
9
Target Price
$5.01
$23.00
AVG Volume (30 Days)
1.2M
355.4K
Earning Date
03-16-2026
02-25-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
1.57
Revenue
$946,327,000.00
$246,718,000.00
Revenue This Year
$2.64
$6,924.79
Revenue Next Year
$2.95
N/A
P/E Ratio
N/A
$11.37
Revenue Growth
3.10
37798.31
52 Week Low
$1.20
$9.12
52 Week High
$3.21
$22.55

Technical Indicators

Market Signals
Indicator
GETY
KROS
Relative Strength Index (RSI) 49.94 39.72
Support Level $1.23 $17.80
Resistance Level $1.33 $19.13
Average True Range (ATR) 0.05 0.64
MACD 0.01 -0.14
Stochastic Oscillator 86.36 9.17

Price Performance

Historical Comparison
GETY
KROS

About GETY Getty Images Holdings Inc.

Getty Images Holdings Inc. is a visual content creator and marketplace that offers a full range of content solutions. Through its Getty Images, Stock, and Unsplash brands, websites, and APIs, it serves customers around the world by allowing them to discover, purchase, and share visual content from photographers, illustrators, image partners, and videographers. The company generates a majority of its revenue through subscriptions, offering various subscription products on the Getty Images, iStock, and Unsplash websites. It operates and manages one operating segment, which is the business of developing and commercializing visual content. Geographically, the company generates maximum revenue from the Americas, followed by Europe, the Middle East and Africa, and the Asia-Pacific region.

About KROS Keros Therapeutics Inc.

Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.

Share on Social Networks: